SCHEMBL6948560

SCHEMBL6948560

NCCON=C(CCn1ccnc1)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.54
TBXA2R P21731 4/20 0.46
TP53 P04637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TSHR P16473 1/20 0.45
ALDH1A1 P00352 1/20 0.43
TBXAS1 P24557 2/20 0.42
PGR P06401 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CYP2C9 P11712 1/20 0.42
ADRB3 P13945 1/20 0.42
IDO1 P14902 1/20 0.42
ADRA2B P18089 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947048 0.93 SLC6A4 (0.58) SLC6A4TBXA2RTP53KDM4ETSHR
Hydrochloric Acid SCHEMBL6950832 0.92 SLC6A4 (0.57) SLC6A4TBXA2RTP53KDM4ETSHR
Fumaric Acid SCHEMBL8670305 0.92 TBXA2R (0.47) SLC6A4TBXA2RKDM4EALDH1A1TBXAS1
Fumaric Acid SCHEMBL8670308 0.92 TBXA2R (0.47) SLC6A4TBXA2RKDM4EALDH1A1TBXAS1
SCHEMBL6946854 0.88 SLC6A4 (0.54) SLC6A4TBXA2RTBXAS1CYP3A4CYP2D6
SCHEMBL6950410 0.88 TBXA2R (0.58) TBXA2RTBXAS1CYP19A1
Hydrochloric Acid SCHEMBL8666242 0.87 SLC6A4 (0.53) SLC6A4TBXA2RTBXAS1CYP3A4CYP2D6
SCHEMBL6943201 0.86 MEN1 (0.50) SLC6A4TBXA2RTSHRALDH1A1TBXAS1
SCHEMBL6948590 0.85 CYP1A2 (0.56) SLC6A4TBXA2RTBXAS1CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6949500 0.84 CYP1A2 (0.55) SLC6A4TBXA2RTBXAS1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP claimed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US claimed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP claimed
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP disclosed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP disclosed